https://ivri.berkeley.edu/the-yin-yang-of-cancer-and-infectious-disease/2017-05-19T16:40:14+00:00https://ivri.berkeley.edu/listening-to-each-other-infectious-disease-and-cancer-immunology/2017-05-19T16:40:05+00:00https://ivri.berkeley.edu/nih-partners-with-11-leading-biopharmaceutical-companies-to-accelerate-the-development-of-new-cancer-immunotherapy-strategies-for-more-patients/2017-10-30T13:43:06+00:00https://ivri.berkeley.edu/aduro-biotech-bolsters-intellectual-property-position-in-sting-field-with-two-new-patents/2017-10-31T21:03:12+00:00https://ivri.berkeley.edu/eva-harris-lab-from-uc-berkeley-school-of-public-health-shows-evidence-of-antibody-dependent-enhancement-during-dengue-infections/2017-11-10T05:15:29+00:00https://ivri.berkeley.edu/daniel-portnoy-one-of-three-uc-berkeley-faculty-elected-to-the-national-academy-of-inventors/2017-12-13T03:16:50+00:00https://ivri.berkeley.edu/jennifer-doudna-and-james-allison-receive-awards-from-the-national-academy-of-sciences/2018-01-18T05:13:09+00:00https://ivri.berkeley.edu/uc-berkeley-celebrates-150-years/2018-01-31T04:42:23+00:00https://ivri.berkeley.edu/donate-to-ivri-for-the-big-give/2018-03-07T19:13:33+00:00https://ivri.berkeley.edu/nih-statement-on-world-tuberculosis-day-march-24-2018/2018-03-23T18:29:35+00:00https://ivri.berkeley.edu/development-of-a-new-vaccine-against-tuberculosis-from-sarah-stanleys-lab-in-the-school-of-public-health-at-berkeley-in-collaboration-with-aduro-biotech/2018-05-10T17:23:42+00:00https://ivri.berkeley.edu/dragonfly-therapeutics-highlighted/2018-05-10T18:02:27+00:00https://ivri.berkeley.edu/dan-fletchers-lab-shows-that-antibody-dependent-phagocytosis-by-immune-cells-depends-on-size-of-protein-recognized-by-the-antibody/2018-06-28T19:18:46+00:00https://ivri.berkeley.edu/uc-berkeley-scientists-use-a-crispr-cas9-gold-nanoparticle-to-edit-genes-linked-to-autism-spectrum-disorders-in-the-brains-of-mice/2018-06-28T19:15:20+00:00https://ivri.berkeley.edu/congratulations-to-nobel-laureate-james-allison-uc-berkeley-research-led-to-nobel-prize-winning-immunotherapy/2018-10-01T18:20:45+00:00https://ivri.berkeley.edu/nobel-prize-winning-immunotherapy-research-conducted-at-uc-berkeley/2018-10-01T18:21:11+00:00https://ivri.berkeley.edu/uc-berkeley-aduro-biotech-collaborate-to-discover-cancer-treatments/2018-11-16T19:28:26+00:00https://ivri.berkeley.edu/photo-of-jim-receiving-nobel-prize/2019-01-24T22:48:33+00:00https://ivri.berkeley.edu/photos-james-allison-receiving-the-nobel-prize/2019-01-24T22:39:25+00:00https://ivri.berkeley.edu/contribution-of-nk-cells-to-immunotherapy-mediated-by-pd-1-pd-l1-blockade/2019-02-26T20:51:56+00:00https://ivri.berkeley.edu/tumor-derived-cgamp-triggers-a-sting-mediated-interferon-response-in-non-tumor-cells-to-activate-the-nk-cell-response/2019-04-05T23:22:38+00:00https://ivri.berkeley.edu/slc19a1-cyclic-dinucleotide-transporter-manuscript/2019-02-26T21:16:11+00:00https://ivri.berkeley.edu/listening-to-each-other-infectious-disease-and-cancer-immunology-2/2019-02-26T21:26:31+00:00https://ivri.berkeley.edu/lecture-to-be-given-by-professor-david-raulet-at-osher-lifelong-learning-institute-on-april-10/2019-04-05T23:23:35+00:00https://ivri.berkeley.edu/berkeley-talks-professor-david-raulet-on-the-revolution-of-cancer-immunology/2019-04-29T22:28:08+00:00https://ivri.berkeley.edu/ivri-congratulates-david-raulet-to-his-election-to-the-national-academy-of-sciences/2019-09-11T23:20:08+00:00https://ivri.berkeley.edu/akkermansia-muciniphila-induces-intestinal-adaptive-immune-responses-during-homeostasis/2019-08-05T16:39:23+00:00https://ivri.berkeley.edu/jim-allison-breakthrough/2019-08-08T17:00:19+00:00https://ivri.berkeley.edu/ivri-congratulates-faculty-david-raulet-and-aduro-biotech-collaborators-on-their-landmark-nature-paper/2019-09-30T01:01:56+00:00https://ivri.berkeley.edu/september-26-is-mesothelioma-awareness-day-designed-to-raise-awareness-of-mesothelioma-cancer-research-advancements-and-the-dangers-of-asbestos-ivri-is-happy-to-collaborate-with-colin-ruggiero-of/2019-09-13T21:28:06+00:00https://ivri.berkeley.edu/jim-allison-breakthrough-opening-on-10-4-at-the-landmark-clay-theatre-in-sf-and-shattuck-cinemas-in-berkeley/2019-09-23T23:34:22+00:00https://ivri.berkeley.edu/ivri-congratulates-faculty-gregory-m-barton-and-nevan-krogan-on-their-two-landmark-nature-papers-this-work-helps-us-understand-how-finely-regulated-interactions-between-proteins-and-their-location-e/2019-10-09T18:03:26+00:00https://ivri.berkeley.edu/ivri-investigator-co-authors-nature-paper-on-tumor-response-to-immunotherapy/2019-10-30T02:08:15+00:00https://ivri.berkeley.edu/ivri-faculty-director-and-cancer-survivor-david-raulet-featured-in-2-part-pbs-documentary/2019-12-05T23:27:59+00:00https://ivri.berkeley.edu/jam-allison-breakthrough-has-made-the-washington-posts-10-best-movies-of-2019/2019-12-12T00:53:58+00:00https://ivri.berkeley.edu/ivri-faculty-director-professor-raulet-publishes-on-how-natural-killer-cells-could-be-used-to-combat-cancer/2020-03-23T21:53:05+00:00https://ivri.berkeley.edu/toll-like-receptors-tlrs-are-in-front-line-defense-molecules-which-recognize-pathogen-dna-and-rna-however-their-unique-position-raises-the-risk-of-initiating-inappropriate-autoimmune-responses-pr/2020-05-14T01:01:03+00:00https://ivri.berkeley.edu/ivri-is-proud-to-feature-fab-article-from-uc-berkeley-pr-jay-groves-understanding-how-t-cell-receptors-tcrs-are-activated-is-fundamental-in-the-cancer-immunotherapy-field-the-present-study-is/2020-05-26T19:26:57+00:00https://ivri.berkeley.edu/dan-fletchers-lab-reveals-how-a-viral-pathogen-hijacks-branched-actin-network-assembly-to-drive-cell-cell-fusion-a-mechanism-essential-for-tissue-development-and-used-by-some-viruses-to-form/2020-05-26T20:38:12+00:00https://ivri.berkeley.edu/ivri-faculty-director-david-raulet-comments-in-this-week-science-edition-a-publication-by-zhou-et-al-showing-that-cytotoxic-lymphocytes-both-kill-target-cells-and-activate-additional-inflammatory/2020-06-09T22:48:47+00:00https://ivri.berkeley.edu/bristol-myers-squibb-invests-in-dragonfly-therapeutics-a-company-co-founded-by-ivri-faculty-director-david-raulet/2020-07-06T17:52:57+00:00https://ivri.berkeley.edu/dr-winotos-team-new-study-supported-by-ivri-and-aduro-biotech-grant-043572-demonstrates-a-novel-approach-that-leads-to-effective-t%e2%80%90cell-responses-against-tumors-in-mice-with-pote/2020-07-15T22:14:12+00:00https://ivri.berkeley.edu/congratulations-to-ivri-investigator-russell-vance-on-receiving-the-cancer-research-institutes-cri-2020-william-b-coley-award-to-acknowledge-his-work-on-the-cgas-sting-pathway/2020-09-10T23:38:22+00:00https://ivri.berkeley.edu/livia/2020-09-18T22:45:33+00:00https://ivri.berkeley.edu/jim-allison-breakthrough-wins-2020s-top-international-science-media-award/2020-10-16T18:28:08+00:00https://ivri.berkeley.edu/ivri-faculty-dr-vance-and-his-team-develop-the-first-oral-infection-mouse-model-for-shigella-infection-that-recapitulates-human-disease/2020-10-26T17:10:29+00:00https://ivri.berkeley.edu/750-2/2021-08-23T21:53:49+00:00https://ivri.berkeley.edu/david-h-raulet-ivri-faculty-director-presented-the-martin-meyerson-berkeley-faculty-research-lecture-not-all-killers-are-bad-how-natural-killer-cells-protect-you-from-cancer/2022-05-23T22:54:19+00:00https://ivri.berkeley.edu/ivri-faculty-director-david-raulet-and-collaborators-reviewed-in-nature-reviews-immunology-why-natural-killer-nk-cells-are-emerging-as-important-new-additions-to-the-cancer-therapeutic-arsenal/2024-03-14T18:08:49+00:00https://ivri.berkeley.edu/uc-berkeley-assistant-professor-in-immunology-michel-dupage-published-in-cancer-immunology-separating-the-good-from-the-bad-tumor-infiltrating-tregs-have-increased-fucosylation/2024-03-14T18:07:20+00:00https://ivri.berkeley.edu/ivri-faculty-director-publishes-new-potential-target-for-immunotherapy/2024-03-14T22:05:15+00:00